These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3548315)

  • 1. Lack of value for cisplatin added to mitomycin-doxorubicin combination chemotherapy for carcinoma of unknown primary site. A randomized trial.
    Eagan RT; Therneau TM; Rubin J; Long HJ; Schutt AJ
    Am J Clin Oncol; 1987 Feb; 10(1):82-5. PubMed ID: 3548315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination chemotherapy in metastatic tumors of unknown origin. 5-Fluorouracil, adriamycin and mitomycin C for adenocarcinomas and adriamycin, vinblastine and mitomycin C for anaplastic carcinomas.
    Sulkes A; Uziely B; Isacson R; Brufman G; Biran S
    Isr J Med Sci; 1988; 24(9-10):604-10. PubMed ID: 3204009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combination of cisplatin, doxorubicin, and mitomycin (PAM) compared with the FAM regimen in treating advanced gastric carcinoma. A phase II randomized trial of the Italian Oncology Group for Clinical Research.
    De Lisi V; Cocconi G; Angelini F; Cavicchi F; Di Costanzo F; Gilli G; Rodinò C; Soldani M; Tonato M; Finardi C
    Cancer; 1996 Jan; 77(2):245-50. PubMed ID: 8625230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastatic adenocarcinoma of unknown primary site. A randomized study of two combination chemotherapy regimens.
    Milliken ST; Tattersall MH; Woods RL; Coates AS; Levi JA; Fox RM; Raghavan D
    Eur J Cancer Clin Oncol; 1987 Nov; 23(11):1645-8. PubMed ID: 2448145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination chemotherapy for non-small cell lung cancer with doxorubicin and mitomycin or cisplatin and etoposide.
    Joss RA; Alberto P; Obrecht JP; Barrelet L; Holdener EE; Siegenthaler P; Goldhirsch A; Mermillod B; Cavalli F
    Cancer Treat Rep; 1984 Sep; 68(9):1079-84. PubMed ID: 6090014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Fluorouracil, doxorubicin and mitomycin C (FAM) combination chemotherapy for metastatic adenocarcinoma of unknown primary.
    van der Gaast A; Verweij J; Planting AS; Stoter G
    Eur J Cancer Clin Oncol; 1988 Apr; 24(4):765-8. PubMed ID: 3383976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II randomized trial of cisplatin chemotherapy regimens in the treatment of recurrent or metastatic squamous cell cancer of the cervix: a Southwest Oncology Group Study.
    Alberts DS; Kronmal R; Baker LH; Stock-Novack DL; Surwit EA; Boutselis JG; Hannigan EV
    J Clin Oncol; 1987 Nov; 5(11):1791-5. PubMed ID: 2445932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas.
    Edmonson JH; Ryan LM; Blum RH; Brooks JS; Shiraki M; Frytak S; Parkinson DR
    J Clin Oncol; 1993 Jul; 11(7):1269-75. PubMed ID: 8315424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized comparative trial of sequential versus alternating cyclophosphamide, doxorubicin, and cisplatin and mitomycin, lomustine, and methotrexate in metastatic non-small-cell lung cancer.
    Eagan RT; Frytak S; Richardson RL; Creagan ET; Therneau TM; Coles DT; Jett JR
    J Clin Oncol; 1988 Jan; 6(1):5-8. PubMed ID: 2826714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doxorubicin versus mitomycin versus doxorubicin plus mitomycin in advanced breast cancer: a randomized study.
    Andersson M; Daugaard S; von der Maase H; Mouridsen HT
    Cancer Treat Rep; 1986 Oct; 70(10):1181-6. PubMed ID: 3530444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II study of mitomycin C, cisplatin and continuous infusion 5-fluorouracil (MCF) in the treatment of patients with carcinoma of unknown primary site.
    Macdonald AG; Nicolson MC; Samuel LM; Hutcheon AW; Ahmed FY
    Br J Cancer; 2002 Apr; 86(8):1238-42. PubMed ID: 11953879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer.
    Kim NK; Park YS; Heo DS; Suh C; Kim SY; Park KC; Kang YK; Shin DB; Kim HT; Kim HJ
    Cancer; 1993 Jun; 71(12):3813-8. PubMed ID: 8508349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose mitomycin and weekly low-dose doxorubicin combination chemotherapy for patients with metastatic breast carcinoma previously treated with cyclophosphamide, methotrexate, and 5-fluorouracil.
    Colozza M; Tonato M; Grignani F; Davis S
    Cancer; 1988 Jul; 62(2):262-5. PubMed ID: 3383126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5-fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: a phase II study.
    Hong RL; Sheen TS; Ko JY; Hsu MM; Wang CC; Ting LL
    Br J Cancer; 1999 Aug; 80(12):1962-7. PubMed ID: 10471046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Fluorouracil versus a combination of BCNU, adriamycin, 5-FU and mitomycin C in advanced gastric cancer: a prospective randomized study of the Italian Clinical Research Oncology Group.
    De Lisi V; Cocconi G; Tonato M; Di Costanzo F; Leonardi F; Soldani M
    Recent Results Cancer Res; 1988; 110():212-8. PubMed ID: 3136519
    [No Abstract]   [Full Text] [Related]  

  • 16. A randomized study of two vindesine plus cisplatin-containing regimens with the addition of mitomycin C or ifosfamide in patients with advanced non-small cell lung cancer.
    Rosell R; Abad-Esteve A; Moreno I; Barnadas A; Carles J; Fernandez C; Ribelles N; Culubret M
    Cancer; 1990 Apr; 65(8):1692-9. PubMed ID: 2156597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A randomized trial comparing vindesine plus cisplatin with mitomycin C, vindesine plus cisplatin in patients with advanced non-small cell lung cancer].
    Fujii M; Kiura K; Okabe K; Toki H; Kimura M
    Gan To Kagaku Ryoho; 1987 Sep; 14(9):2676-81. PubMed ID: 2820312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in metastatic carcinoma of unknown primary.
    Pasterz R; Savaraj N; Burgess M
    J Clin Oncol; 1986 Nov; 4(11):1652-7. PubMed ID: 3095502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of anthracyclines in the treatment of gastric cancer.
    Wadler S; Green M; Muggia F
    Cancer Treat Rev; 1985 Jun; 12(2):105-32. PubMed ID: 3902215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined cisplatin, doxorubicin, and mitomycin for the treatment of advanced pleural mesothelioma: a phase II FONICAP trial. Italian Lung Cancer Task Force.
    Pennucci MC; Ardizzoni A; Pronzato P; Fioretti M; Lanfranco C; Verna A; Giorgi G; Vigani A; Frola C; Rosso R
    Cancer; 1997 May; 79(10):1897-902. PubMed ID: 9149015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.